Zassida

Zassida (Azacitidine) is a prescription medication used for certain blood cancers. This injectable form is administered under medical supervision. Commonly prescribed for myelodysplastic syndromes and acute myeloid leukemia. Store as directed by a healthcare professional.

Azacitidine is primarily used to treat myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). It belongs to a class of drugs known as demethylating agents, which help slow the growth of abnormal blood cells. Patients often ask, 'what is Azacitidine used for'—it is prescribed when the bone marrow does not produce healthy blood cells. It may also be used in other conditions as determined by a healthcare provider.

Azacitidine works by helping the bone marrow produce normal blood cells. Patients may notice improved blood counts over time with regular use. Some individuals report mild fatigue or digestive changes during treatment. Effects vary by individual response and medical condition.

This medication should only be handled and administered by a healthcare professional. Keep the vial refrigerated until use and protect from light. Do not use if the solution is discolored or contains particles. Always follow the handling and disposal instructions provided by your pharmacist or doctor.

Azacitidine may interact with other medications, including certain chemotherapy drugs and immunosuppressants. Alcohol use should be discussed with a healthcare provider. Inform your doctor about all prescription, over-the-counter, and herbal products you are taking. Avoid receiving live vaccines while on this treatment unless approved by your physician.